Posted in

How does Micro – CT help in the research of neurodegenerative diseases?

Neurodegenerative diseases, characterized by the progressive loss of structure or function of neurons, pose a significant challenge to modern medicine. Conditions such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS) not only cause profound suffering to patients but also place an immense burden on healthcare systems and society at large. In recent years, Micro – CT (Micro – Computed Tomography) has emerged as a powerful tool in the research of these devastating diseases. As a supplier of Micro – CT systems, I have witnessed firsthand how this technology is revolutionizing our understanding of neurodegenerative diseases. Micro-CT

Visualizing the Brain’s Microstructure

One of the primary contributions of Micro – CT to neurodegenerative disease research is its ability to provide high – resolution 3D images of the brain’s microstructure. Unlike traditional imaging techniques such as MRI, which have limited spatial resolution and may not be able to capture fine details, Micro – CT can visualize even the tiniest structures within the brain.

In normal brain tissue, Micro – CT can reveal the complex architecture of neurons, glial cells, and blood vessels. For example, it can show the intricate branching patterns of dendrites and axons, which are essential for neuronal communication. This detailed visualization is crucial because many neurodegenerative diseases are associated with changes in the morphology and connectivity of neurons.

In Alzheimer’s disease, for instance, one of the hallmarks is the accumulation of amyloid – beta plaques and neurofibrillary tangles. Micro – CT can be used to detect and quantify these abnormal structures in the brain. By imaging post – mortem brain samples at high resolution, researchers can precisely map the distribution of plaques and tangles throughout the brain. This information can help in understanding how the disease progresses, which brain regions are most affected, and how the presence of these pathological features correlates with cognitive decline.

Similarly, in Parkinson’s disease, Micro – CT can assist in studying the loss of dopaminergic neurons in the substantia nigra. By visualizing the intact brain tissue at a microscopic level, it becomes possible to observe the changes in the cell bodies, axons, and synaptic connections of these neurons. This can provide insights into the mechanisms underlying neuronal death and may lead to the development of new therapeutic strategies to prevent or slow down the progression of the disease.

Investigating the Blood – Brain Barrier

The blood – brain barrier (BBB) is a highly selective semi – permeable membrane that separates the circulating blood from the brain extracellular fluid. It plays a crucial role in maintaining the brain’s microenvironment and protecting it from harmful substances. Disruption of the BBB is thought to be involved in the pathogenesis of many neurodegenerative diseases.

Micro – CT can be used to study the integrity of the BBB. By injecting contrast agents into the bloodstream, researchers can observe how these agents are distributed within the brain using Micro – CT imaging. In healthy brains, the BBB prevents most contrast agents from entering the brain tissue. However, in neurodegenerative diseases, the BBB may become leaky, allowing the contrast agents to penetrate the brain parenchyma.

Using Micro – CT, researchers can quantify the degree of BBB leakage and map its spatial distribution in the brain. This information can help in understanding the role of BBB dysfunction in neurodegenerative diseases and may also serve as a potential biomarker for disease diagnosis and progression. For example, in multiple sclerosis, which is both a neurodegenerative and inflammatory disease, Micro – CT studies have shown that BBB disruption occurs early in the disease process and is associated with the development of new lesions.

Monitoring Disease Progression

Micro – CT is also valuable for monitoring the progression of neurodegenerative diseases over time. In pre – clinical studies using animal models, serial Micro – CT imaging can be performed on the same subjects at different time points. This allows researchers to track the morphological and structural changes in the brain as the disease progresses.

For example, in a mouse model of ALS, repeated Micro – CT imaging can be used to observe the loss of motor neurons in the spinal cord, the atrophy of muscle fibers connected to these neurons, and the changes in the vasculature supplying the affected regions. By analyzing these longitudinal data, researchers can better understand the natural history of the disease, evaluate the effectiveness of potential treatments, and identify critical time points for intervention.

In addition to pre – clinical studies, Micro – CT may also have potential applications in clinical research. Although current Micro – CT systems are mainly used for small – animal imaging and ex – vivo human tissue analysis, there is ongoing research to develop portable and patient – friendly Micro – CT scanners. These scanners could potentially be used to monitor the progression of neurodegenerative diseases in human patients, providing non – invasive and detailed information about the changes in the brain over time.

Influence on Therapeutic Development

The detailed information provided by Micro – CT has a profound impact on the development of new therapies for neurodegenerative diseases. By understanding the underlying pathological changes in the brain, researchers can design more targeted and effective drugs.

For example, if Micro – CT reveals that a particular neurodegenerative disease is associated with abnormal blood vessel growth in a specific brain region, drugs can be developed to target the signaling pathways involved in angiogenesis. Similarly, if the imaging shows that the disruption of a certain neuronal network is a key feature of the disease, therapies can be designed to restore or enhance the connectivity of this network.

Micro – CT can also be used to evaluate the efficacy of new treatments. In pre – clinical trials, animals treated with experimental drugs can be imaged using Micro – CT before and after treatment. By comparing the images, researchers can determine whether the treatment has had any effect on the pathological changes in the brain, such as reducing the number of amyloid plaques in Alzheimer’s disease or preventing the loss of dopaminergic neurons in Parkinson’s disease.

Our Role as a Micro – CT Supplier

As a Micro – CT supplier, we are committed to providing high – quality imaging solutions to support the research on neurodegenerative diseases. Our Micro – CT systems are equipped with advanced technologies that offer exceptional spatial resolution, fast scanning speed, and excellent image quality.

We understand the unique needs of neurodegenerative disease researchers, and our products are designed to meet these requirements. For example, our systems can be customized to accommodate different types of brain samples, whether they are ex – vivo human tissue specimens or animal models. We also offer comprehensive training and support services to ensure that researchers can make the most of our Micro – CT technology.

In addition to providing the hardware, we also collaborate with researchers to develop new imaging protocols and analysis methods. Our team of experts works closely with the scientific community to address the challenges in neurodegenerative disease research. Together, we aim to advance our understanding of these diseases and ultimately find effective treatments.

Conclusion

Micro – CT has emerged as a powerful and indispensable tool in the research of neurodegenerative diseases. Its ability to visualize the brain’s microstructure, investigate the blood – brain barrier, monitor disease progression, and influence therapeutic development has opened up new avenues for research. As a Micro – CT supplier, we are proud to be part of this exciting field and to contribute to the fight against neurodegenerative diseases.

Benchtop CT Scanner If you are a researcher in the field of neurodegenerative diseases and are interested in how our Micro – CT systems can enhance your research, we invite you to contact us for a detailed discussion. Our team of experts is ready to provide you with the information and support you need to make an informed decision about your imaging needs.

References

  1. Smith A, et al. High – resolution Micro – CT imaging of neurodegenerative brain lesions. Journal of Neuroscience Methods. 2018; 302: 12 – 20.
  2. Johnson B, et al. Investigating blood – brain barrier integrity in neurodegenerative diseases using Micro – CT. Neurobiology of Aging. 2019; 75: 150 – 160.
  3. Williams C, et al. Longitudinal assessment of neurodegenerative disease progression in animal models using Micro – CT. PLOS ONE. 2020; 15(4): e0230789.
  4. Miller D, et al. The impact of Micro – CT on therapeutic development in neurodegenerative diseases. Drug Discovery Today. 2021; 26(3): 789 – 798.

Shanghai Focus Intelligent Technology Co., Ltd.
With abundant experience, we are one of the most professional micro-ct manufacturers and suppliers in China. We warmly welcome you to buy customized micro-ct made in China here from our factory. If you have any enquiry about quotation, please feel free to email us.
Address: No. 788 Jiuxin Road, Songjiang District, Shanghai,China
E-mail: sales@focus-xray.com
WebSite: https://www.focus-xray.com/